Marol (Tramadol Hydrochloride)

Tramadol produces pain relief by binding to μ‑opioid receptors in the central nervous system and by inhibiting the reuptake of norepinephrine and serotonin. This dual action enhances descending inhibitory pathways, reducing the perception of pain.

The appropriate dose of Marol is determined by the prescribing clinician based on the patient’s pain severity, medical history, and response to therapy. Dosage adjustments may be needed for renal or hepatic impairment, and the prescriber will provide specific instructions.

Safety data for tramadol in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant. Healthcare providers will evaluate individual circumstances before prescribing.

To request Marol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with stronger opioids such as morphine, tramadol offers moderate analgesia with a lower risk of respiratory depression but carries a unique profile of serotonergic activity and seizure risk. It is often chosen when a milder opioid effect is desired or when patients have contraindications to stronger agents.

Marol tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Marol is taken orally, usually with a full glass of water. It may be taken with or without food, but taking it with food can reduce gastrointestinal upset. The tablet should be swallowed whole and not crushed or chewed.

Serious risks include respiratory depression, especially in opioid‑naïve patients or when combined with other depressants; seizures, which are more likely at high doses or with interacting medications; and serotonin syndrome when used with serotonergic drugs. Prompt medical attention is required if any of these occur.

Marol should be avoided in patients with a known hypersensitivity to tramadol or any component of the formulation, those taking monoamine oxidase inhibitors, individuals with uncontrolled epilepsy, and patients with severe respiratory insufficiency. Clinicians will assess contraindications before prescribing.